Skip to content

MDMA: all studies

Page 249 of 346: studies 2,481 to 2,490 of 3,454, newest first. Back to the MDMA overview

Research

Australian University Residential College Students' Awareness of and Attitudes Toward Drug Checking Services.

Substance Use & Misuse July 12, 2026 Nina Pocuca, Anthony Barnett, Chloe Alcorn et al.

While drug checking services can serve to minimize harms and support rapid monitoring of drug supplies to detect emerging drug trends and potential epidemics, uptake of these services is often limited. As awareness of and attitudes toward drug checking can impact uptake, the present study examined these variables and associated determinants among Australian university residential college...

DOI: 10.1080/10826084.2026.2698844 (opens in new tab) Full text (opens in new tab) Drug checking College students Drug use Harm reduction

Psychedelic-Assisted Psychosexual Therapy

July 10, 2026 Lohani Noor

A resurgent therapeutic frontier, the contemporary renaissance in psychedelic science has accelerated investigation of classic serotonergic psychedelics (psilocybin, lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), mescaline), empathogenic entactogenic agents (3,4-methylenedioxymethamphetamine (MDMA)), and glutamatergic dissociatives (ketamine) as adjuncts to psychotherapy. While...

The Entrepreneurship of Psychedelic Negativity: Psymposia, Trauma, Iatrogenic Harm, and Prohibition 2.0

Contemporary Drug Problems July 10, 2026 Oliver Davis, Sophie Casey

This article outlines a skeptical appraisal of Psymposia, a small but influential self-appointed psychedelics “watchdog” organization based in the United States of America, which played a significant role in blocking regulatory approval for MDMA as a treatment for PTSD in 2024. Contextualized close analysis of its “Power Trip” podcast series, which focused on sexual abuse in the psychedelic...

DOI: 10.1177/00914509261466701 (opens in new tab) Sensationalism Entrepreneurship Culpability Skepticism +12

Pharmacological characterization of new psychoactive substances

University of Vienna July 8, 2026 Ronald Derndorfer

Neue psychoaktive Substanzen gewinnen zunehmend an Bedeutung im Bereich der öffentlichen Gesundheit und könnten neue therapeutische Ansätze für psychiatrische und kognitive Störungen ermöglichen. MDMA wird derzeit in Phase-3-Studien als Ergänzung zur Psychotherapie zur Behandlung von PTBS untersucht. Nach zwei Phase-3-Studien forderte die FDA in einem Complete Response Letter weitere...

DOI: 10.25365/thesis.81446 (opens in new tab) Drug In vitro In vivo Ex vivo +2

REKONSTRUKSI EPISTEMOLOGIS TEORI SELF TRANCENDENCE ABRAHAM MASLOW BERBASIS KARAKTERISTIK ULUL ALBAB DALAM AL-QUR'AN

TAJDID Jurnal Pemikiran Keislaman dan Kemanusiaan July 6, 2026 Muhammad Aminullah, Yan Yan Supriatman

Krisis eksistensial dan kebangkrutan spiritual masyarakat modern pada dekade ketiga abad ke-21 menyingkap keterbatasan paradigma psikologi sekuler Barat. Meskipun Abraham Maslow menggagas teori Self-Transcendence sebagai puncak hierarki kebutuhan, konsep tersebut mengidap bias antroposentrisme-sekuler yang mereduksi pengalaman transendental sebatas sensasi psikologis sesaat tanpa jangkar...

DOI: 10.52266/tajdid.v10i1.7038 (opens in new tab) Qur’anic interpretation studies

Psychedelics and longevity: implications for lifespan, healthspan and functional aging

Longevity July 5, 2026 Mark Haden, Birgitta Woods, Tina Woods et al.

Longevity science has increasingly shifted its focus from extending lifespan to improving healthspan, the years lived in good physical, cognitive, and social health. While much research targets biological hallmarks of aging, emerging frameworks emphasize upstream psychosocial drivers such as chronic stress, trauma, social isolation, and health behavior. In parallel, research on psychedelic...

DOI: 10.1080/30653495.2026.2696224 (opens in new tab) Senescence Nervous system Disease

Reducing Research Harms: Analysis and Recommendations for Researching Schedule I Substances Under the HALT Fentanyl Act

Journal of Science Policy & Governance July 2, 2026 Alaina M Jaster, Joseph J. Hennessey, Tanner L. Anderson et al.

Research on Schedule I substances in the United States remains heavily restricted by the regulatory structure imposed by the Controlled Substances Act (CSA). This regulatory system creates significant Research Harm, which can be defined as the restriction or deterrence of legitimate scientific inquiry arising from governmental actions, such as regulatory controls or criminal prohibitions that...

DOI: 10.38126/jspg280109 (opens in new tab) Sanctions Confusion Controlled substance Schedule +7

Policy Considerations for Psychedelics in Research and Medicine – What’s Next on the Schedule?

Journal of Science Policy & Governance July 2, 2026 Matthew A. Boehm, Oriana Mayorga

There is growing interest in psychedelic compounds such as psilocybin, 3,4-metheylenedioxymethamphetamine (MDMA), lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT) given emerging research on potential uses as treatments for a variety of health conditions. The United States Food and Drug Administration (FDA) has granted multiple “Breakthrough Therapy” designations to various...

Psicodélicos en psiquiatría: un modelo multidimensional para el análisis crítico del campo. Farmacología, actores y política sanitaria en la expansión terapéutica

Revista de Psiquiatría del uruguay July 1, 2026 María M. Penengo, Marta Vázquez, Laura Ramos et al.

página 48|Revista de Psiquiatría del Uruguay|Volumen 90 Nº 1 Julio 2026| Psicodélicos en psiquiatría: un modelo multidimensional para el análisis...Resumo Nos últimos anos, o renovado interesse pelo uso medicinal dos psicodélicos adquiriu um caráter hipermidiatizado, estendendo sua presença de contextos clínicos e rituais tradicionais para cenários mais amplos, nos quais os objetivos...

ЭЛЕКТРОЭНЦЕФАЛОГРАФИЧЕСКИЙ СКРИНИНГ ПОТРЕБИТЕЛЕЙ ПСИХОСТИМУЛЯТОРОВ

cyberleninka.ru June 29, 2026 Минин А. В., Ишеков Н. С., Еремеева А. А. et al.

Употребление психостимуляторов остается одной из ключевых проблем общественного здоровья, так как связано с развитием тяжелых расстройств и значительными социальными последствиями. Несмотря на накопленные данные о клинических проявлениях, нейрофизиологические механизмы их воздействия и формирования зависимости до конца не изучены. В условиях растущей распространенности амфетаминов, кокаина,...

DOI: 10.24412/2220-7880-2026-2-90-94 (opens in new tab) Action physics Fusible alloy Identification biology